profit from every $100 of sales.
$0$100
Aurora Cannabis
$5.05-1.17% today
+11.0% in 1 year
1-year low $2.581-year high $5.57
Trading in the middle of its range for the past year.
The essentials
Four questions every investor asks, answered in one line each.
more sales each year, on average, 2021 to 2025.
0%20% a year
You pay $297.22 for every $1 of profit it makes in a year.
CheapExpensive
It holds more cash than debt.
No debt5 years
Money in, money out
What Aurora Cannabis sold, what it kept, and what it did with the cash.
Sales went from CA$245 million in 2021 to CA$343 million in 2025, with CA$1.59 million of profit last year.
SalesProfit
Aurora Cannabis vs. similar companies
Aurora Cannabis grows in the middle of these 5 and is the most expensive for its profits.
| Company | Profit from $100 of sales | Sales growth a year | Price per $1 of profit |
|---|---|---|---|
| Aurora Cannabis | 297.2× · Very expensive | ||
 Merck KGaA | 25.9× · Fair price | ||
 Takeda Pharmaceutical | 98.8× · Very expensive | ||
 Galderma Group | 89.1× · Very expensive | ||
 Teva Pharmaceutical Industries | 35.8× · Expensive |
AI analysis
An AI analyst reads Aurora Cannabis's last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisFull statementsIncome, balance sheet and cash flow, year by year
Income statement
| In millions of CAD | 2021 | 2022 | 2024 | 2025 |
|---|---|---|---|---|
| 245 | 221 | 270 | 343 | |
| -22 | 21 | 132 | 188 | |
| -247 | -219 | -31 | 10 | |
| -535 | -1,555 | -11 | 51 | |
| -694 | -1,718 | -69 | 2 | |
| -41.00 | -79.90 | -1.52 | 0.04 | |
| -8.8% | 9.6% | 48.9% | 54.6% | |
| -100.6% | -99.1% | -11.5% | 2.9% | |
| -282.8% | -776.0% | -25.7% | 0.5% |
Balance sheet
| In millions of CAD | 2021 | 2022 | 2024 | 2025 |
|---|---|---|---|---|
| Total assets | 2,605 | 1,084 | 839 | 853 |
| Cash | 421 | 438 | 136 | 138 |
| Total debt | 400 | 269 | 105 | 105 |
| Total liabilities | 567 | 422 | 237 | 244 |
| 2,038 | 662 | 560 | 567 | |
| 17 | 21 | 43 | 55 | |
| -20.5% | -139.8% | -5.2% | 3.4% | |
| -34.0% | -259.5% | -12.4% | 0.3% |
Cash flow
| In millions of CAD | 2021 | 2022 | 2024 | 2025 |
|---|---|---|---|---|
| -211 | -110 | -69 | 16 | |
| 53 | 32 | 17 | 19 | |
| -264 | -142 | -85 | -3 | |
| Dividends paid | – | – | – | – |
| – | – | – | – | |
| 20 | 14 | 13 | 12 |
Valuation
- 297.2×
- 26.1×
- –
- 0.5×
- 1.4×
- –
- 8.6×
- -0.6%
- 0.3%
- 0.0%
Profitability
- 54.6%
- 2.9%
- 0.5%
- 3.4%
- 0.1%
- -77.3%
- -14.1%
- -12.5%
- 0.1%
- 1.6%
Growth
- +8.8%
- –
- −1,166.6%
- –
- +27.5%
Financial health
- -8.5×
- 0.05
- 4.0%
- 0.1×
- 5.94
- 3.32
- 0.52
How it ranks in Healthcare
Each dot is where the company stands among every company over $300M in the sector. Further right is better.
Bottom 33%of 958
Bottom 32%of 888
Bottom 1%of 600
Bottom 44%of 889
Bottom 34%of 987
What analysts expect
- Average price target
- $5.92
- Range
- $1.00 – $8.75
These targets were collected on May 20, 2026 and our analyst feed has not updated since, so we no longer compare them with today's price.
Recent earnings
Our results feed has not updated since May 21, 2026. Results reported after that are not in this table yet.
| Date | EPS | Expected | Surprise |
|---|---|---|---|
| Feb 4, 2026 | 0.09 | 0.10 | −7.4% |
| Nov 5, 2025 | 0.09 | 0.03 | +200.0% |
| Aug 6, 2025 | -0.19 | 0.18 | −205.6% |
| Jun 18, 2025 | 0.07 | 0.11 | −36.4% |
| Feb 5, 2025 | 0.06 | -0.09 | +166.7% |
| Nov 6, 2024 | 0.04 | -0.22 | +118.2% |
| Aug 7, 2024 | -0.11 | -0.35 | +68.6% |
| Jun 20, 2024 | 0.11 | -0.18 | +161.1% |
News
Earnings Week Ahead: CSCO, CRWV, PLUG, ALC, AMAT, ACB, RKLB, ASTS, and moreSeeking Alpha · Nov 8, 2026Curaleaf challenge to Aurora Cannabis at-the-market program failsSeeking Alpha · Oct 26, 2026Aurora targets 30,000 driverless trucks, aims $5B revenue by 2030Seeking Alpha · Sep 28, 2026Autonomous trucking company Aurora looks to accelerate toward profitabilityCNBC · Sep 22, 2026Is Curaleaf Stock a Buy With Its Attempted Hostile Takeover of Aurora Cannabis Under Way?Yahoo Finance · Aug 20, 2026Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
The seven classic investing rulebooks
1/7Passes 1 of 7. Each bar is how well the company fits that investor's published rules, from 0 to 100; 60 or more counts as a pass.
Warren Buffett
29No pass
Benjamin Graham
73Pass
Philip Fisher
30No pass
Peter Lynch
49No pass
Joel Greenblatt
24No pass
Charlie Munger
29No pass
Terry Smith
26No pass
Questions about Aurora Cannabis
Is Aurora Cannabis a good stock to buy?
A business with weak numbers, priced as if everything goes right. 1 of the 7 famous investors' published rulebooks we apply pass it. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the Aurora Cannabis AI analysis
What does Aurora Cannabis do?
Aurora Cannabis Inc. is a leading company in the global cannabis industry, focusing on the cultivation, production, and sale of various cannabis and cannabis-derived products across Canada and internationally. It is in Drug Manufacturers - Specialty & Generic.
Does Aurora Cannabis pay a dividend?
No. Aurora Cannabis does not pay a dividend at the moment.
Is Aurora Cannabis stock halal?
Yes. Aurora Cannabis passes our halal screen: its business is permitted and its debt is 22% of its market value, under the 30% limit. How we check
How has Aurora Cannabis stock done over the past year?
Up 11.0% over the past twelve months, to $5.05. It traded between $2.58 and $5.57 and is 9.3% below its high.
Who are Aurora Cannabis's competitors?
The largest listed companies in the same industry are Merck KGaA, Takeda Pharmaceutical, Galderma Group and Teva Pharmaceutical Industries. The peers table on this page compares their profit, growth and price with Aurora Cannabis's.
Prices: daily closes to Nov 11, 2026. Fundamentals: company reports via invest-like data.